Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces $525 Million Accretive Core-Area Saskatchewan Asset Acquisition (click to learn more) Safe Supply Streaming Portfolio Company Safety Strips, Provides Corporate Update (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nautilus Biotechnology Inc NAUT

Technology Advertising Agencies Scientific & Technical Instruments
Nautilus Biotechnology, Inc. is a development stage life sciences company. The Company is engaged in creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company is focused on transforming the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. The Company's platform... see more

Recent & Breaking News (NDAQ:NAUT)

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023

GlobeNewswire January 26, 2023

Nautilus Biotechnology Expands to San Diego

GlobeNewswire January 26, 2023

Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG)

GlobeNewswire January 19, 2023

Nautilus Biotechnology Launches "First Access Challenge"

GlobeNewswire November 16, 2022

Nautilus Biotechnology Reports Third Quarter 2022 Financial Results

GlobeNewswire November 1, 2022

Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022

GlobeNewswire October 5, 2022

Nautilus Biotechnology to Participate in the Capital One Spatial Biology & Proteomics Summit

GlobeNewswire September 23, 2022

Nautilus Biotechnology Joins Human Proteome Organization (HUPO) Industrial Advisory Board

GlobeNewswire September 1, 2022

Nautilus Biotechnology to Participate in the Morgan Stanley Global Healthcare Conference

GlobeNewswire August 30, 2022

Nautilus Biotechnology Reports Second Quarter 2022 Financial Results

GlobeNewswire August 2, 2022

Nautilus Biotechnology Appoints Eric Spence as Vice President of Instrument Engineering and Ken Kuhn, Ph.D., as Vice President of Reagent and Platform Development

GlobeNewswire August 1, 2022

Nautilus Biotechnology to Announce Second Quarter 2022 Financial Results on August 2, 2022

GlobeNewswire July 13, 2022

Nautilus Biotechnology Reports First Quarter 2022 Financial Results

GlobeNewswire May 3, 2022

Nautilus Biotechnology Appoints Gwen Weld as Chief People Officer and Sheri Wilcox, Ph.D., as Vice President of Affinity Reagent Development

GlobeNewswire April 12, 2022

Nautilus Biotechnology to Announce First Quarter 2022 Financial Results on May 3, 2022

GlobeNewswire April 7, 2022

Nautilus Biotechnology to Present at EuPA and AACR Meetings

GlobeNewswire April 4, 2022

Nautilus Biotechnology Appoints Karen Akinsanya, Ph.D., to Board of Directors

GlobeNewswire March 31, 2022

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2021 Financial Results

GlobeNewswire February 24, 2022

Nautilus to Participate in the 42nd Annual Cowen Health Care Conference

GlobeNewswire February 16, 2022

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022

GlobeNewswire January 27, 2022